Literature DB >> 11829326

Diminished circadian blood pressure rhythm in patients with asymptomatic normotensive pheochromocytoma.

T Zelinka1, J Widimský, J Weisserová.   

Abstract

In our study, the circadian blood pressure (BP) rhythm was studied in subjects with asymptomatic and normotensive pheochromocytoma. We have therefore performed 24-hour BP monitoring not only in 6 subjects with asymptomatic pheochromocytoma, but also in 33 patients with symptomatic pheochromocytoma and in 10 normotensive subjects, who served as a control group. Circadian BP rhythm was expressed by assessing a relative night-time BP decline. We found a similar BP rhythm, catecholamine excretion and tumor size in subjects with both forms of pheochromocytoma. Subjects with asymptomatic pheochromocytoma had a significantly lower night-time systolic BP decline (P=0.01) and diastolic BP decline (P=0.006) than normotensive controls. We conclude that the attenuated night-time BP decline in normotensive and asymptomatic subjects with pheochromocytoma might be a possible sign of partial desensitization of the cardiovascular system to catecholamines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11829326

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  5 in total

Review 1.  [Preoperative α-adrenoceptor block in asymptomatic pheochromocytoma? Pro].

Authors:  L Bracker; S Rath; H Dralle; M Bucher
Journal:  Chirurg       Date:  2012-06       Impact factor: 0.955

Review 2.  Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas.

Authors:  Aoife J Lowery; Siun Walsh; Enda W McDermott; Ruth S Prichard
Journal:  Oncologist       Date:  2013-04-10

3.  Ambulatory blood pressure monitoring in secondary arterial hypertension due to adrenal diseases.

Authors:  Michele Ceruti; Luigi Petramala; Dario Cotesta; Sabrina Cerci; Valentina Serra; Chiara Caliumi; Monica Iorio; Giorgio De Toma; Antonio Ciardi; Domenico Vitolo; Claudio Letizia
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-09       Impact factor: 3.738

Review 4.  Circadian Clock, Cell Division, and Cancer: From Molecules to Organism.

Authors:  Anton Shostak
Journal:  Int J Mol Sci       Date:  2017-04-20       Impact factor: 5.923

Review 5.  Hypoxia Signaling and Circadian Disruption in and by Pheochromocytoma.

Authors:  Mouna Tabebi; Peter Söderkvist; Lasse D Jensen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-16       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.